Aevi Genomic Medicine - 8 Year Stock Split History | GNMX

Stock split history for Aevi Genomic Medicine since 2011. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Aevi Genomic Medicine Annual Stock Splits
Aevi Genomic Medicine Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.014B $0.000B
Aevi Genomic Medicine Inc. is focused on genomic medicine. The Company focuses on translating genetic discoveries into novel therapies. Its product candidates include AEVI-001 and AEVI-002 which are in clinical trial stage. Aevi Genomic Medicine Inc., formerly known as Medgenics Inc., is based in WAYNE, United States.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $51.113B 9.20
Teva Pharmaceutical Industries (TEVA) Israel $17.145B 5.92
Mylan (MYL) United Kingdom $14.813B 6.27
Bausch Health Cos (BHC) Canada $8.874B 6.31
Dr Reddy's Laboratories (RDY) India $6.725B 26.82
Supernus Pharmaceuticals (SUPN) United States $1.990B 18.47
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.976B 3.21
Homology Medicines (FIXX) United States $1.032B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.980B 91.04
CymaBay Therapeutics (CBAY) United States $0.770B 0.00
Voyager Therapeutics (VYGR) United States $0.590B 0.00
Assembly Biosciences (ASMB) United States $0.478B 0.00
Akorn (AKRX) United States $0.440B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.383B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.220B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.131B 0.00
Sol-Gel Technologies (SLGL) Israel $0.131B 0.00
Acasti Pharma (ACST) Canada $0.084B 0.00
Teligent (TLGT) United States $0.070B 0.00
Agile Therapeutics (AGRX) United States $0.068B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.065B 0.00
Evoke Pharma (EVOK) United States $0.027B 0.00
China Pharma Holdings (CPHI) China $0.014B 0.00